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Abstract When rat macropbages were converted to foam cells 
with acetylated low density lipoprotein (acetyl-LDL) and then 
reacted with high density lipoprotein (HDL) and an inhibitor of 
acyl-coenzyme A:cholesterol acyltransferase (58-035) (sequen- 
tial incubation system), 58-035 did not enhance HDL-induced 
cholesterol efflux. In contrast, when macrophages were exposed 
to acetyl-LDL in the presence of both HDL and 58-035 (simulta- 
neous incubation system), HDL-induced cholesterol efflux was 
enhanced 1.6-fold by 58-035. Cholesterol efllux with HDL alone 
was 2-fold greater in simultaneous incubation than in sequential 
incubation. These results suggest the presence of an efficient 
cholesterol efflux pathway in simultaneous incubation which is 
not available in sequential incubation. This pathway, which we 
refer to as the neutral cholesterol ester bydrolase-independent 
pathway, is characterized by the efllux of lysosome-derived 
cholesterol without re-esterification. 
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1. Introduction 
Macrophage foam cells (MFC) are a prominent feature of 
the early stage of atherosclerotic lesions [l]. Macrophages are 
known to take up chemically modified low density lipoproteins 
(modified LDLs) such as acetyl-LDL and oxidized LDL 
through the scavenger receptor pathway, which leads to the 
accumulation of intracellular cholesteryl esters (CE) or the for- 
mation of foam cells [2]. Among these modified LDLs, oxidized 
LDL is regarded as a major atherogenic lipoprotein in vivo [3]. 
Cellular CE in MFC undergoes continual hydrolysis to free 
cholesterol by neutral cholesterol ester hydrolase (NCEH) and 
re-esterification to CE by acyl-coenzyme A : cholesterol 
acyltransferase (ACAT). This metabolic cycle is known as the 
cholesteryl ester cycle [4]. 
In contrast to LDL, high density lipoprotein (HDL) is widely 
believed to play a protective role in atherogenesis because of 
its capacity to promote cholesterol efflux from peripheral cells, 
the first step in ‘reverse cholesterol transport’ [5-S]. Most of the 
previous studies on HDL-mediated cholesterol efflux from 
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MFC have been performed with established foam cells in which 
macrophages were first converted to foam cells with athero- 
genie lipoproteins, such as beta-VLDL and acetyl-LDL, fol- 
lowed by incubation with HDL (sequential incubation, Fig. 1A) 
[4-71. However, in some experiments, cells were incubated with 
atherogenic lipoproteins simultaneously with HDL, and the 
inhibitory effect on CE accumulation in macrophages was ex- 
amined (simultaneous incubation, Fig. 1B) [&lo]. The simulta- 
neous incubation system was first introduced to this field by 
Innerarity et al. [lo]. Using the simultaneous incubation system, 
we recently demonstrated that discoidal complexes of apoA-I 
and dimyristoylphosphatidylcholine, a model of nascent HDL 
in vivo, interacted with acetyl-LDL and reduced its ligand ac- 
tivity for the macrophage scavenger receptor, indicating that 
this incubation system could be used to demonstrate another 
aspect of HDL anti-atherogenicity [9]. We also observed that 
HDL did not affect the cellular uptake of acetyl-LDL, but 
significantly inhibited CE accumulation by promoting cholest- 
erol efflux [8,9]. However, the mechanisms and the pathophys- 
iological implications of the anti-atherogenic properties of 
HDL in simultaneous incubation is unclear [&lo]. In the pres- 
ent study, we directly compared the efficiencies of HDL and an 
ACAT inhibitor (58-035) in enhancing cholesterol efflux in 
sequential incubation with those in simultaneous incubation 
and correlated them with the in vivo effects of an ACAT inhib- 
itor in the progression and the regression of experimental ath- 
erosclerosis [ll]. The results showed that HDL and 58-035 
reduced cellular cholesterol much more efficiently in the simul- 
taneous incubation system than in the sequential incubation 
system. 
2. Materials and methods 
2.1. Materials 
[la, 2a.(n)-‘HlCholesteryl oleoyl ether (1.7 TBq/mmol) and Na? 
(3.7 GBq/ml) were purchased from Amersham. The ACAT inhibitor 
58-035 was a generous gift from Dr. J.G. Heider of Sandoz, Inc. (East 
Hanover, NJ). Tissue culture media and reagents were obtained from 
Life Technologies, Inc. Other chemicals were of the best grade available 
from commercial sources. 
2.2. Lipoproteins and their modification 
LDL (d = 1.019-1.063 g/ml) and HDL (d = 1.063-1.21 g/ml) were 
isolated by sequential ultr&entrifugation. Traces of apolipoprotein B 
and E were removed from HDL bv a heparin agarose column 1121. 
Acetyl-LDL was prepared as previdusly described [13]. Iodinatioh df 
acetyl-LDL with “‘1 was performed according to the method of McFar- 
lane [14]. Acetyl-LDL was also labeled with the non-hydrolyzable 
cholesteryl ester analog [3H]cholesteryl oleoyl ether, as previously de- 
scribed [9]. Protein concentrations were determined by BCA protein 
assay reagents [5] and expressed as mg protein/ml. 
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2.3. Cell culture 
Rat peritoneal macrophages were collected (1 x lO’/rat) from non- 
stimulated male Wistar rats (17&200 g) [ 151, and suspended at 2 x 1 06/ 
ml with Dulbecco’s modified Eagle’s medium (DMEM) containing 3% 
bovine serum albumin (BSA), N-2-hydroxyethylpiperazine-N’-2- 
ethanesulfonic acid (10 mM, pH 7.4), streptomycin (0.1 mg/ml) and 
penicillin (100 U/ml) (DMEM 3% BSA). One ml of the cell suspension 
was added to each 35-mm dish, and the cells were incubated at 37°C 
in 5% CO, for 2 h. Cell monolayers which formed were washed 3 times 
with 1 ml of PBS and used for the following experiments. 
Macrophage monolayers were incubated in two incubation systems 
(Fig. 1). In sequential incubation (Fig. 1 A), cells were initially converted 
to foam cells by incubating them for 18 h with 5O,@ml of acetyl-LDL. 
After washing three times with 1 ml of PBS, cells were incubated for 
an additional 18 h with 0.25 mg/ml of HDL and/or 5 pg/ml of 58-035. 
In simultaneous incubation (Fig. lB), cells were incubated with 50 
&ml of acetyl-LDL simultaneously with HDL and/or 58-035. After 
washing three times with 1 ml of PBS, cells were incubated for an 
additional 18 h with medium alone so that the total incubation time in 
simultaneous incubation was equal to that in sequential incubation. In 
a preliminary experiment, cholesterol esterification was completely in- 
hibited by 58-035 at 5 &ml when macrophages were incubated with 
50 pglml of acetyl-LDL and 0.1 mM of [3H]oleate. 
2.4. Mass determination of celhdar cholesterol contents 
Cellular lipids were extracted and both the free cholesterol mass and 
CE mass were quantified by a modification [8] of the enzymatic 
fluorometric methods of Heider and Boyett [16]. Cells were dissolved 
in 0.1 M of NaOH to determine cell proteins using a BCA protein assay 
reagent [5]. 
2.5. Endocytic degradation of “2’I-acetyl-LDL by rat macrophages 
Macrophage monolayers (2 x 10”) prepared as above were incubated 
with 50 pg/ml of ‘*‘I-acetyl-LDL (79 cpm/ng protein) in the absence or 
presence of 0.25 mg/ml of HDL and 5 &ml of 58-035. Endocytic 
degradation was determined by trichloroacetic acid-soluble radioactiv- 
ity in the medium as follows. Ice-cold 40% trichloroacetic acid (0.25 ml) 
was added to 0.75 ml of the medium to a final concentration of 10%. 
AgNO, (0.7 M, 0.2 ml) was then added to the mixture and incubated 
at room temperature for 30 min to precipitate free iodine [17]. After 
centrifugation at 700 x g for 10 min, supernatants were counted by a 
gamma-counter. 
2.6. Statistical analysis 
Data were evaluated by Student’s t-test. When the P-value was less 
than 0.05, the difference was judged to be significant. 
3. Results 
To confirm that HDL and 58-035 did not affect the endocytic 
pathway of acetyl-LDL, rat macrophages were incubated with 
1251-acetyl-LDL in the absence or presence of HDL and 58-035. 
Endocytic degradation of ‘251-acetyl-LDL was not altered by 
the addition of HDL and/or 58-035 (data not shown). Moreo- 
ver, the accumulation of cellular [3H]cholesteryl oleoyl ether 
was also not affected by these agents when incubated with 
[3H]cholesteryl oleoyl ether-labeled acetyl-LDL (data not 
shown). Thus, neither HDL nor 58-035 has any effects on the 
endocytic pathway of acetyl-LDL or its cholesterol supply to 
cells under the present conditions. 
Efficiencies of HDL and 58-035 in promoting cholesterol 
efilux from rat macrophages were examined in two experimen- 
tal systems (Fig. 1). When macrophages were converted to 
foam cells with acetyl-LDL and then reacted with HDL (se- 
quential incubation ), the CE level was reduced by only 12% 
(Fig. 2A). The addition of S-035 to HDL did not significantly 
enhance the HDL-induced reduction in the cellular CE level, 
or that of total cholesterol (Fig. 2A), as we previously demon- 
strated [7]. When cells were incubated with 58-035 alone, the 
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Fig. 1. Two different experimental systems for examining the effects of 
HDL and the ACAT inhibitor 58-035 on cholesterol efflux from rat 
macrophages. In sequential incubation (panel A), macrophages were 
incubated for 18 h with acetyl-LDL to be converted to foam cells. After 
washing, cells were incubated for an additional 18 h with HDL and/or 
58-035. In simultaneous incubation (panel B), macrophages were incu- 
bated for 18 h with acetyl-LDL in the presence of HDL and/or 58-035. 
After washing, cells were incubated for an additional 18 h with medium 
alone before harvesting cells. 
CE level was significantly reduced while total cholesterol was 
not significantly altered (Fig. 2A). 
When macrophages were incubated with acetyl-LDL to- 
gether with HDL from the onset of the experiment (simultane- 
ous incubation), HDL reduced the cellular CE level by 51% 
(Fig. 2B), which was significantly greater than the CE reduction 
by HDL (12%) (P < 0.01) in sequential incubation (Fig. 2A). 
When 58-035 was added to HDL. the cellular CE level was 
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Fig. 2. Effects of HDL and the ACAT inhibitor 58-035 on cholesterol 
et&x from rat macrophages in sequential (A) and simultaneous (B) 
incubation. A. Rat macrophages (2 x 106) were converted to foam cells 
by 18 h of incubation with 50.~g/ml of acetyl-LDL. After washing, cells 
were incubated for an additional 18 h with 0.25 mg/ml of HDL and/or 
5 &ml of 58-035. B. Rat macrophages (2 x 106) were incubated for 18 
h with 50figlml ofacetyl-LDL together with 0.25 mg/ml of HDL and/or 
5 ,@ml of 58-035. After washing, cells were incubated for an additional 
18 h with medium alone. Cellular lipids were extracted and cholesterol 
mass was determined as described in the ‘Materials and Methods’. Each 
value is the mean of quadruplicate experiments with a bar showing SD. 
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A. Sequential incubation 
B. Simultaneous incubation 
Fig. 3. Effects of HDL and 58-035 on cellular total cholesterol in rat 
macrophages. The effects of HDL and 58-035 on the levels of total 
cellular cholesterol in rat macrophages were calculated and re-plotted 
from the data shown in Fig. 3. N. S.; Not significant. 
markedly reduced to the basal level (Fig. 2B). The ability of 
HDL to reduce total cholesterol was also markedly enhanced 
by 58-035, from 36% to 59% in simultaneous incubation 
(P < 0.01) (Fig. 2B), which was in sharp contrast to the results 
in sequential incubation (Fig. 2A). When cells were incubated 
with acetyl-LDL and 58-035, free cholesterol accumulated in 
cells while a significant amount of CE was detected (Fig. 2B). 
However, when the cells were harvested just after 18-h incuba- 
tion with acetyl-LDL and 58-035, cellular CE was virtually at 
the basal level (data not shown). This indicates that a significant 
portion of free cholesterol was converted to CE in the absence 
of 58-035 during an additional 18 h incubation with medium 
alone (see Fig. l), probably because the free cholesterol level 
far exceeded the threshold level for re-esterification to CE by 
ACAT [18]. 
Since the endocytic degradation of acetyl-LDL and the sub- 
sequent cholesterol supply were not affected by HDL or 58-035, 
the reducing effects of HDL and 58-035 on cellular cholesterol 
levels in simultaneous incubation are most likely due to their 
effects on cholesterol efflux. From the data shown in Fig. 2, we 
determined the absolute amounts of cholesterol efflux from rat 
macrophages, and the results were re-plotted in Fig. 3. It be- 
came clear that the amount of cholesterol efflux with HDL 
alone was 2-fold greater in simultaneous incubation than in 
sequential incubation (P < 0.01). Moreover, addition of 58-035 
to HDL in the simultaneous incubation system enhanced HDL- 
induced cholesterol efflux by 1.6-fold (P < O.Ol), but had no 
effect in the sequential incubation system. 
4. Discussion 
In the present study, we used two experimental protocols to 
determine the effect of HDL and the ACAT inhibitor 58-035 
on cholesterol efIlux from rat macrophages (Fig. 1). One was 
a conventional protocol in which macrophages were first con- 
verted to foam cells with acetyl-LDL and then incubated with 
HDL (sequential incubation) (Fig. 1A). In the other protocol, 
macrophages were incubated with both acetyl-LDL and HDL 
from the onset of the experiment (simultaneous incubation) 
(Fig. 1B). 
ACAT inhibitors are well known to enhance HDL-induced 
cholesterol efflux from mouse MFC in sequential incubation 
because they increase cellular free cholesterol derived from 
cytoplasmic CE [7,19,20]. However, in contrast to mouse MFC, 
58-035 did not enhance HDL-induced cholesterol efflux from 
rat MFC (Figs. 2A and 3), as we recently reported [7]. This 
species difference may be due to the slower turnover rate of the 
CE cycle in rat MFC [7]. In sequential incubation, the enhance- 
ment of HDL-induced cholesterol eRIux by 58-035 is closely 
related to the turnover rate of the CE cycle in each species. 
In contrast to sequential incubation, 58-035 strongly en- 
hanced cholesterol efflux from rat macrophages in simultane- 
ous incubation (Figs. 2B and 3). This suggests that the mecha- 
nism for cholesterol efflux in simultaneous incubation may be 
different from that in sequential incubation. Fig. 4 shows pos- 
sible intracellular pathways for cholesterol transport in each 
incubation system. In sequential incubation, cholesterol efflux 
greatly depends on the hydrolytic conversion of cytoplasmic 
CE to free cholesterol. We tentatively referred to this efflux 
pathway the ‘NCEH-dependent pathway’. The simultaneous 
incubation system may involve an intracellular pathway for 
cholesterol efflux in addition to the NCEH-dependent path- 
way. In this system, some of the free cholesterol released into 
the cytoplasm from lysosomes after degradation of acetyl-LDL 
is esterified to CE, which could enter the NCEH-dependent 
pathway (Fig. 4). However, some of the free cholesterol re- 
leased into the cytoplasm from lysosomes is directly trans- 
ported to plasma membranes to be effluxed by HDL without 
undergoing esterification by ACAT (NCEH-independent path- 
+ FC - 
NCEH 
I; NCEH-dependent pathway 
II; NCEH-independent pathway 
Fig. 4 Schematic representation of the pathways for intracellular 
cholesterol transport in rat macrophages. In the sequential incubation 
system, cholesterol etl’mx from rat MFC depends on the rate of CE 
conversion to cholesterol by NCEH. Since the turnover rate of the CE 
cycle in rat MFC is significantly slower than that in mouse MFC, 
58-035 does not significantly enhance HDL-induced cholesterol efflux 
in rat macrophages [7]. However, in the simultaneous incubation sys- 
tem, free cholesterol generated by the action of lysosomal acid lipase 
enters the NCEH-independent pathway in the presence of 58-035. In 
the absence of 58-0351 some df the lysosome-derived cholesterol is 
esterified to CE by ACAT and enters the NCEH-denendent oathwav. 
The data shown in Fig. 3 strongly suggest that the NkEH-independent 
pathway is more efficient than the NCEH-dependent pathway in rat 
macrophages. 
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way) (Fig. 4) Since the simultaneous incubation system con- 
tains both pathways, if 58-035 is present in this system, only the 
NCEH-independent pathway is available for cholesterol efflux 
because esterification of free cholesterol is blocked by the inhib- 
itor. 
In the simultaneous incubation system without 58-035, the 
absolute amount of cholesterol efllux induced by HDL was 
2-fold greater than that in the sequential incubation system 
(Fig. 3). Moreover, in simultaneous incubation with 58-035, the 
amount of HDL-induced cholesterol eftlux was still 3.5-fold 
greater than that in the sequential incubation system. There- 
fore, it is likely that cholesterol efllux by the NCEH-independ- 
ent pathway may be much more efficient than that by the 
NCEH-dependent pathway in rat macrophages (Fig. 4). 
Although the two different intracellular cholesterol pathways 
shown in Fig. 4 have been known, the present study demon- 
strated for the first time that NCEH-independent pathway is 
much more efficient for cholesterol elllux than NCEH-depend- 
ent pathway. Since HDL is expected to co-localize with athero- 
genie LDLs such as Ox-LDL in atherosclerotic lesions in situ, 
the NCEH-independent pathway might play a crucial role in 
HDL-mediated cholesterol efflux in atherogenesis, and particu- 
larly in protecting macrophages from CE accumulation in the 
initial phase of foam cell formation. 
This notion is supported by the following observations. The 
half-time for conversion of cytoplasmic CE to free cholesterol 
in rat MFC is approximately 36 h , which is much longer than 
that in mouse MFC (12 h) [7]. In contrast, the half-times for 
conversion of lysosomal LDL cholesteryl esters to free cholest- 
erol by acid lipase (acidic cholesterol ester hydrolase) are re- 
portedly 37 min in Chinese hamster ovary cells [21] and 60 min 
in rat hepatoma cells (FuSAH) [22]. Moreover, transport of 
lysosomal cholesterol to plasma membrane is also reportedly 
very rapid (within 1 h) [21,22]. Therefore, the most time-con- 
suming process in cholesterol efflux in rat macrophages is 
the NCEH-catalyzed conversion of cytoplasmic CE to free 
cholesterol. 
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